AMINOCAPROIC ACID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminocaproic Acid, and when can generic versions of Aminocaproic Acid launch?
Aminocaproic Acid is a drug marketed by Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Zenara, Ajenat Pharms, Amneal, Annora Pharma, Aurobindo Pharma, Carnegie, Epic Pharma Llc, MSN, Regcon Holdings, Sciegen Pharms, Sunny, Taro, Tp Anda Holdings, Vistapharm Llc, Adaptis, Ani Pharms, and Somerset Theraps Llc. and is included in twenty-six NDAs.
The generic ingredient in AMINOCAPROIC ACID is aminocaproic acid. There are six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminocaproic Acid
A generic version of AMINOCAPROIC ACID was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMINOCAPROIC ACID?
- What are the global sales for AMINOCAPROIC ACID?
- What is Average Wholesale Price for AMINOCAPROIC ACID?
Summary for AMINOCAPROIC ACID
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 26 |
| Finished Product Suppliers / Packagers: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 39 |
| Drug Prices: | Drug price information for AMINOCAPROIC ACID |
| What excipients (inactive ingredients) are in AMINOCAPROIC ACID? | AMINOCAPROIC ACID excipients list |
| DailyMed Link: | AMINOCAPROIC ACID at DailyMed |
Recent Clinical Trials for AMINOCAPROIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Zagazig University | NA |
| Minia University | Phase 3 |
| NYU Langone Health | N/A |
Pharmacology for AMINOCAPROIC ACID
| Drug Class | Antifibrinolytic Agent |
| Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for AMINOCAPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for AMINOCAPROIC ACID
US Patents and Regulatory Information for AMINOCAPROIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunny | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060-002 | Nov 27, 2018 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sunny | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060-001 | Nov 27, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Abraxis Pharm | AMINOCAPROIC ACID | aminocaproic acid | INJECTABLE;INJECTION | 070522-001 | Jun 17, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vistapharm Llc | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 212814-001 | Feb 26, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Msn | AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 212938-002 | Sep 13, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 212780-001 | Aug 23, 2019 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Luitpold | AMINOCAPROIC ACID | aminocaproic acid | INJECTABLE;INJECTION | 071192-001 | Dec 1, 1987 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
